Alexis K. Smith

791 total citations
10 papers, 513 citations indexed

About

Alexis K. Smith is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alexis K. Smith has authored 10 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alexis K. Smith's work include Prostate Cancer Treatment and Research (6 papers), Cancer, Lipids, and Metabolism (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Alexis K. Smith is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Cancer, Lipids, and Metabolism (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Alexis K. Smith collaborates with scholars based in United States, Japan and Belgium. Alexis K. Smith's co-authors include Hiroji Uemura, Angela Lopez‐Gitlitz, Paul N. Mainwaring, Fred Saad, Matthew R. Smith, Julie N. Graff, David Olmos, Eric J. Small, Boris Hadaschik and Stéphane Oudard and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Alexis K. Smith

10 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexis K. Smith United States 7 341 145 126 122 118 10 513
R. Nevin Murray Canada 7 540 1.6× 203 1.4× 60 0.5× 242 2.0× 173 1.5× 10 651
Curtis Dunshee United States 11 424 1.2× 225 1.6× 18 0.1× 110 0.9× 130 1.1× 41 548
John Bernard France 5 363 1.1× 135 0.9× 15 0.1× 129 1.1× 135 1.1× 8 472
Friedrich Graf Finckenstein United States 10 175 0.5× 332 2.3× 102 0.8× 21 0.2× 81 0.7× 17 481
Albaha Barqawi United States 5 187 0.5× 167 1.2× 34 0.3× 59 0.5× 70 0.6× 10 351
Ines Figueiredo United Kingdom 11 356 1.0× 237 1.6× 14 0.1× 93 0.8× 232 2.0× 26 576
W D Figg United States 5 222 0.7× 99 0.7× 18 0.1× 28 0.2× 96 0.8× 6 357
Valentina Tateo Italy 10 150 0.4× 205 1.4× 44 0.3× 31 0.3× 96 0.8× 36 437
Prabhakar Pandey United States 11 299 0.9× 156 1.1× 17 0.1× 31 0.3× 174 1.5× 15 584
Julio A. Peguero United States 12 241 0.7× 368 2.5× 92 0.7× 27 0.2× 78 0.7× 49 517

Countries citing papers authored by Alexis K. Smith

Since Specialization
Citations

This map shows the geographic impact of Alexis K. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexis K. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexis K. Smith more than expected).

Fields of papers citing papers by Alexis K. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexis K. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexis K. Smith. The network helps show where Alexis K. Smith may publish in the future.

Co-authorship network of co-authors of Alexis K. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Alexis K. Smith. A scholar is included among the top collaborators of Alexis K. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexis K. Smith. Alexis K. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
3.
Smith, Matthew R., Fred Saad, Simon Chowdhury, et al.. (2020). Apalutamide and Overall Survival in Prostate Cancer. European Urology. 79(1). 150–158. 181 indexed citations
4.
Dogdas, Belma, Christopher Kanan, Patricia Raciti, et al.. (2020). Computational pathological identification of prostate cancer following neoadjuvant treatment.. Journal of Clinical Oncology. 38(15_suppl). e14052–e14052. 4 indexed citations
5.
Small, Eric J., Fred Saad, Simon Chowdhury, et al.. (2020). Final survival results from SPARTAN, a phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC).. Journal of Clinical Oncology. 38(15_suppl). 5516–5516. 35 indexed citations
6.
Small, Eric J., Fred Saad, S. Chowdhury, et al.. (2019). Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer. Annals of Oncology. 30(11). 1813–1820. 99 indexed citations
7.
Smith, Matthew R., Fred Saad, S. Chowdhury, et al.. (2019). Apalutamide (APA) and overall survival (OS) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): Updated results from the phase III SPARTAN study. Annals of Oncology. 30. v325–v325. 12 indexed citations
8.
Smith, Alexis K., et al.. (2018). JNJ-64457107, a CD40 Agonist, Induces Cell Death in BCL6hiIRF4neg GCB Subtype of DLBCL. Blood. 132(Supplement 1). 1674–1674. 1 indexed citations
9.
Wiehagen, Karla R., Natasha Girgis, Douglas H. Yamada, et al.. (2017). Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity. Cancer Immunology Research. 5(12). 1109–1121. 135 indexed citations
10.
Smith, Alexis K., James W. Hodge, Charlie Garnett‐Benson, et al.. (2013). Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death. Journal for ImmunoTherapy of Cancer. 1(S1). 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Nevin Murray Breakdown of academic impact, for papers by Curtis Dunshee Breakdown of academic impact, for papers by John Bernard Breakdown of academic impact, for papers by Friedrich Graf Finckenstein Breakdown of academic impact, for papers by Albaha Barqawi Breakdown of academic impact, for papers by Ines Figueiredo Breakdown of academic impact, for papers by W D Figg Breakdown of academic impact, for papers by Valentina Tateo Breakdown of academic impact, for papers by Prabhakar Pandey Breakdown of academic impact, for papers by Julio A. Peguero
Rankless by CCL
2026